| 注册
首页|期刊导航|中华医学杂志(英文版)|Increased procoagulant activity of red blood cells in the presence of cisplatin

Increased procoagulant activity of red blood cells in the presence of cisplatin

L(U) Cheng-fang YU Hong-juan HOU Jin-xiao ZHOU Jin

中华医学杂志(英文版)2008,Vol.121Issue(18):1775-1780,6.
中华医学杂志(英文版)2008,Vol.121Issue(18):1775-1780,6.

Increased procoagulant activity of red blood cells in the presence of cisplatin

Increased procoagulant activity of red blood cells in the presence of cisplatin

L(U) Cheng-fang 1YU Hong-juan 1HOU Jin-xiao 1ZHOU Jin1

作者信息

  • 1. Department of Hematology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China
  • 折叠

摘要

Abstract

Background Cisplatin based chemotherapy is a well recognized risk factor for coagulation disordrs and thrombosis.The pathophysiological mechanisms by which cisplatin promote thrombosis are not well understood.Methods Red blood cells (RBCs) were separated from peripheral blood of patients with breast cancer (n=10) and healthy adults (n=6) and treated with cisplatin. Coagulation time of RBCs was assessed by one step recalcification time and the productions of thrombin, intrinsic and extrinsic factor Xa were measured in the presence or absence of various concentrations of lactadherin. Exposed phosphatidylserine was stained with lactadherin and observed by confocal microscopy and flow cytometry.Results Neither fresh RBCs nor RBCs treated without cisplatin had potent procoagulant activity. Cisplatin treatment increased procoagulant activity of RBCs in a cell number- and concentration-dependent manner. Exposed phosphatidylserine was stained with lactadherin and after cisplatin treatment, strong fluorescence was revealed by confocal microscopy. Lactadherin bound RBCs from patients with breast cancer increased from (1.9±0.5)% on control RBCs to (68.0±3.5)% on RBCs treated with 10 pmol/L cisplatin for 24 hours.Conclusions Cisplatin treatment increases procoagulant activity of RBCs, which have a strong association with exposure of phosphatidylserine. The increased procoagulant activity may contribute to the pathogenesis of thrombophilia during cisplatin based chemotherapy in breast cancer patients.

关键词

procoagulant activity/red blood cell/phosphatidylserine/cisplatin/lactadherin

Key words

procoagulant activity/red blood cell/phosphatidylserine/cisplatin/lactadherin

分类

医药卫生

引用本文复制引用

L(U) Cheng-fang,YU Hong-juan,HOU Jin-xiao,ZHOU Jin..Increased procoagulant activity of red blood cells in the presence of cisplatin[J].中华医学杂志(英文版),2008,121(18):1775-1780,6.

基金项目

This study was supported by the grants from the EmphasizedProgram from the Natural Science Foundation of HeilongjiangProvince (No. ZJY0502), the International Cooperation Foundation(No. WH05C01), the National Traditional Chinese Medicine Bureau Research Foundation(No.0607LP15), and the Foundation for Post-graduate of Heilongjiang Province (No.YJSCX20070325HLJ). (No. ZJY0502)

中华医学杂志(英文版)

OACSTPCD

0366-6999

访问量0
|
下载量0
段落导航相关论文